GlassScriptPhysician profile
James Hubbard
NPI 1104232255
$765.09
in general payments reported to CMS, 2019-2025
12 companies · $49.39 in 2025
The $49.39 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.00 · 2020: $456 · 2021: $14.78 · 2022: $16.82 · 2023: $120 · 2024: $58.59 · 2025: $49.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $228.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $249.99 | 2020 | |
| Stryker Corporation | $205.80 | 2020 | |
| Integra Lifesciences Corporation | $71.38 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acumed LLC | $66.97 | 2024-2025 | Acumed, Acumed |
| Medtronic USA, INC. | $50.00 | 2019 | |
| Elite Orthopedics, LLC | $33.57 | 2021-2023 | |
| Endo Pharmaceuticals INC. | $24.07 | 2023 | Xiaflex |
| Axogen | $16.82 | 2022 | |
| Zimmer Biomet Holdings, INC. | $13.54 | 2025 | Juggerknotless Soft Anchor, Activbraid |
| Sanara Medtech INC. | $13.35 | 2023 | Celleraterx |
| Ferring Pharmaceuticals INC. | $12.78 | 2023 | Euflexxa |
| Sonex Health, INC. | $6.82 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hubbard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.